Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-15-019879
Filing Date
2015-06-04
Accepted
2015-06-04 17:49:40
Documents
2
Period of Report
2015-06-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 9556
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 4189
  Complete submission text file 0001127602-15-019879.txt   15391
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BROOKSIDE CAPITAL, LLC JOHN HANCOCK TOWER, 200 CLARENDON ST BOSTON MA 02116
Business Address
Koppel Adam (Reporting) CIK: 0001578965 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 15913903